Previously, we found that the bradykinin/sGC signaling pathway is functional in androgen-dependent LNCaP prostate cancer cells, but is impaired in androgen-independent PC-3 and DU 145 prostate cancer cells [14]. Here, SGCB is linked to prostate carcinoma.